Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

NCT02262455 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Endometrial Cancer
Solid Tumors

Interventions

DRUG: STM 434
DRUG: Liposomal doxorubicin

Sponsor

Santa Maria Biotherapeutics